ClinicalTrials.Veeva

Menu

Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

T

Tanta University

Status

Completed

Conditions

External Oblique Intercostal Plane Block
Thoracotomy
Ketamine
Adjuvant
Pain

Treatments

Drug: 29 ml bupivacaine 0.25% + 1 ml saline
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT07138781
36264PR1282/7/25

Details and patient eligibility

About

The aim of this study is to evaluate the role of ketamine as an adjuvant in external oblique intercostal plane block for post thoracotomy pain.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I-III.
  • Scheduled for open thoracotomy.

Exclusion criteria

  • Patients with neurological or intellectual disability.
  • Infection at the injection site.
  • Opioid addiction.
  • Allergic reaction to local anesthetics.
  • Coagulation abnormalities.
  • Drug abuse.
  • Pregnancy.
  • Severe liver and/or renal failure.
  • Severe cardiovascular problems.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups

Group K
Experimental group
Description:
Patients will receive 29 ml bupivacaine 0.25% + 1 ml ketamine (50 mg) as a study group.
Treatment:
Drug: Ketamine
Group C
Active Comparator group
Description:
Patients will receive 29 ml bupivacaine 0.25% + 1 ml saline as a control group.
Treatment:
Drug: 29 ml bupivacaine 0.25% + 1 ml saline

Trial contacts and locations

1

Loading...

Central trial contact

Mohammed S ElSharkawy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems